Vanguard Global Advisers »

Immunic shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $49k 3.2k 15.37

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Micron Technology (MU)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Rbc Cad (RY)

View all positions for Vanguard Global Advisers

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic